Tuesday, February 23, 2021 1:33:59 PM
No, with. Don’t get me wrong. CBD is still a hot trend. I just feel this company’s cbd products aren’t revolutionizing the industry. They will still elevate the pps.
This company needs to do a few things before I can give them a prospective valuation beyond 0.1. They need to get current and they need to update on the share buy back. That and financials could make this a solid run past 0.1 at some point imo.
The fact that the market is bleeding red right now is not helping. Lots of investors are panic selling, afraid of losing too much. I think that’s a mistake. It’s hard to gauge where this stock should be with yesterday’s tweet. Had this dropped a month ago I would have said we could be at 0.05 easily. However, the timing of the tweet with current market conditions is hindering this from going higher imo.
$SHMN
This company needs to do a few things before I can give them a prospective valuation beyond 0.1. They need to get current and they need to update on the share buy back. That and financials could make this a solid run past 0.1 at some point imo.
The fact that the market is bleeding red right now is not helping. Lots of investors are panic selling, afraid of losing too much. I think that’s a mistake. It’s hard to gauge where this stock should be with yesterday’s tweet. Had this dropped a month ago I would have said we could be at 0.05 easily. However, the timing of the tweet with current market conditions is hindering this from going higher imo.
$SHMN
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
